grey
space
About Us
      Technology      Investors      News / Events      Contact
Advanced Proteome Therapeutics

Investors

Investor Information
We are a reporting company in Canada and file with the Canadian Securities Administrators our annual reports with annual financial statements, interim reports, management information, circulars (proxy statements), press releases, and other items, which are publicly available on SEDAR at www.sedar.com.

For more information and to be put on our email list for the latest company news, please send your name, telephone number and email address to info@encompassinc.ca.

Or call us at:
Encompass Communications Inc.
T 604-630-0770
1-877-566-6592 toll free North America

TSX-V Listed:  APC

CUSIP: 007628

Year End: July 31

Shares Issued and Outstanding:
53,624,000

Transfer Agent:
Computershare Investor Services Inc.

Officers and Directors:           
Dr. Allen (Alexander) Krantz, President, CEO and Director
Dr. Russell E. Phares, Director
Robert Bender, Director
Jean Bellin, Director
Dr. Gary Hayes, MD, Director

Scientific Advisory Board
Professor Paul A. Wender
Professor Stephen Hanessian, F.R.S.C., O.C.
Professor Stephen G. Withers

Auditor:
Davidson & Company LLP

 

space
 
Website and branding by NextPhase Strategy